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Abstract
Background: Modelling is widely used to inform decisions about management of malaria and acute febrile illnesses. Most
models depend on estimates of the probability that untreated patients with malaria or bacterial illnesses will progress to
severe disease or death. However, data on these key parameters are lacking and assumptions are frequently made based on
expert opinion. Widely diverse opinions can lead to conflicting outcomes in models they inform.
Methods and Findings: A Delphi survey was conducted with malaria experts aiming to reach consensus on key parameters
for public health and economic models, relating to the outcome of untreated febrile illnesses. Survey questions were
stratified by malaria transmission intensity, patient age, and HIV prevalence. The impact of the variability in opinion on
decision models is illustrated with a model previously used to assess the cost-effectiveness of malaria rapid diagnostic tests.
Some consensus was reached around the probability that patients from higher transmission settings with untreated malaria
would progress to severe disease (median 3%, inter-quartile range (IQR) 1–5%), and the probability that a non-malaria illness
required antibiotics in areas of low HIV prevalence (median 20%). Children living in low transmission areas were considered
to be at higher risk of progressing to severe malaria (median 30%, IQR 10–58%) than those from higher transmission areas
(median 13%, IQR 7–30%). Estimates of the probability of dying from severe malaria were high in all settings (medians 60–
73%). However, opinions varied widely for most parameters, and did not converge on resurveying.
Conclusions: This study highlights the uncertainty around potential consequences of untreated malaria and bacterial
illnesses. The lack of consensus on most parameters, the wide range of estimates, and the impact of variability in estimates
on model outputs, demonstrate the importance of sensitivity analysis for decision models employing expert opinion.
Results of such models should be interpreted cautiously. The diversity of expert opinion should be recognised when policy
options are debated.
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Introduction
Malaria and acute bacterial infections are major causes of
mortality in resource poor settings, particularly for children.
Although funding and commitment to malaria control efforts have
intensified recently, diagnosis and management of malaria and
other causes of acute infection remains challenging and the cost-
effectiveness of different options is often unclear. Economic
evaluations and other decision models are frequently used to
inform policy-makers about the impact and cost-effectiveness of
different strategies for prevention, diagnosis, and treatment of
malaria and other diseases [1,2,3,4]. Models provide a framework
for decision-making under conditions of uncertainty, outlining
alternative courses of action, and identifying the preferred option
[5]. Decision models can be powerful tools, synthesizing a wide
range of factors, such as the costs and consequences of different
interventions, to produce clear policy recommendations. However,
real data informing key model parameters are often lacking.
Ideally, all parameter values for decision models should be
obtained from robust empirical studies; however this is not always
feasible or ethical. For example, a critical baseline parameter in
models evaluating malaria case management is the probability that
a malaria patient will die in the absence of adequate treatment.
There have been a small number of studies suggesting an estimate
for this value, most notably Greenwood et al in 1991, citing a
mortality of 1% for a malaria attack [6]. Use of incidence and
mortality data from the WHO 2009 malaria report, for instance,
gives a mortality rate of 0.3%, with some regional variation [7].
Such estimates however include both treated and untreated cases.
For obvious ethical reasons, estimates of mortality rates for
untreated cases cannot be collected experimentally; values derived
from expert opinion are often used instead [8,9]. Expert opinion
has been employed to estimate values for parameters in models
evaluating the cost-effectiveness of insecticide treated bed-nets,
diagnostics, and antimalarial treatment [10,11,12,13,14,15], and
these are widely used in policy discussions. However, opinions may
vary considerably, and often these estimates do not account for
explanatory variables such as patient age and malaria transmission
intensity.
Delphi surveys are a well-established technique for gathering
expert opinions which aim to reach a consensus on the parameter
values of interest [16]. The ultimate goal of consensus building is
to minimize the variance around parameter values [17]. The
Delphi process invites input from individuals using a systematic,
anonymous and iterative approach, facilitating a more inclusive
process of determining values than open discussions where a small
number of individuals can dominate discussion and consequent
opinion [18]. Delphi surveys allow a range of individuals to
express their opinion which can then be re-assessed by considering
the input from other participants, with the aim of reaching some
convergence on the values of interest.
In this study, a Delphi survey was conducted with prominent
malaria experts to establish estimates for key parameters to be used
in decision models of malaria case management in malaria-
endemic areas. To test the potential impact of variability in
parameter values on models, the survey results were subsequently
entered in a simplified version of a decision model previously used
to evaluate the cost-effectiveness of rapid diagnostic tests (RDTs)
for malaria [19].
Methods
To inform the Delphi survey questions, previously developed
models assessing strategies for the diagnosis and treatment of acute
febrile illness in malaria-endemic areas were examined, and
central parameters for which data were lacking were identified
using sensitivity testing. These usually rely on expert opinion. The
parameters identified included the following: 1) the probability
that a case of untreated malaria would become severe; 2) the
subsequent probability of death for an untreated severe malaria
episode; 3) the probability that a non-malarial illness was bacterial
and required antibiotic treatment; 4) the probability that a
bacterial infection would become severe if not treated with
antibiotics; and 5) the probability of death, for a severe, untreated
bacterial illness. The Delphi survey questions were designed to
capture estimates for each parameter stratified by malaria
transmission intensity and patient age. The initial questionnaire
and responses are shown in Annex 1 (Annex S1). The questions
were piloted with three expert panellists and revisions made on the
basis of their responses.
Panellists were purposively selected based on their expertise and
international reputation in managing malaria as well as other
infectious diseases in Africa and Asia, their involvement in the
global malaria policy process, and their relevant publications in
the clinical literature. This paper’s authorship includes all
panellists, plus YM and AM who provided economic and
modelling support. All panellists had experience of malaria in
both low and high transmission settings, and the panel was
designed to capture experience from West, East, Central and
Southern Africa, and South and Southeast Asia. In the first round,
the panellists were asked to complete the initial questionnaire,
providing point estimates of probabilities based on their personal
beliefs, and to provide feedback on the survey structure and
questions. To summarize the results of the first round, the mean,
median and range of each parameter estimate were calculated,
and responses were graphed to demonstrate the distribution of
opinion. Panellist comments on the survey were categorised by
topic. The individual responses of each panellist were anonymized
in the summary of each survey round.
Revisions to the survey questionnaire were made based on the
number of times an issue was raised, the practicality of the
suggested change, and its relevance to the context of the survey.
The most significant changes to the questionnaire involved the
stratification of malaria transmission intensity, from three strata
(low, medium and high), to two strata in the revised questionnaire
(low/epidemic-prone and medium/high) [20] to assist clarity of
results. In addition, severe malaria was separated into four
categories: cerebral malaria, severe anaemia, respiratory distress,
and the presence of any of the World Health Organization’s
(WHO) definitions of severe malaria [21]. The questions relating
to non-malarial illnesses were also stratified by areas of low and
high HIV prevalence in the revised questionnaire, shown in Annex
2 (Annex S2).
In the second round of the survey, the panellists were provided
with the revised questionnaire, the results of the first survey, and
the panellists’ comments. The identities of other respondents were
kept confidential. Panellists were asked to complete the revised
questionnaire, providing point estimates of probabilities, with the
aim of developing consensus for the various estimates. The results
of the second round were summarized and graphed, as was done
initially.
To evaluate, by way of an illustration, the impact of the range
different parameter estimates considered likely by panellist on
decision modelling, the Delphi survey results were entered into an
existing representative model designed to evaluate the cost-
effectiveness of using RDTs in the management of febrile patients.
The model is a simplified version of an open-access model that was
developed to support policy decision-making [19]. The model
calculates the net-benefit of using an RDT to diagnose malaria as
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compared to treating febrile patients presumptively with antima-
larials, using cost and effectiveness data from Ugandan children
under five. A positive net-benefit indicates a cost-effective
treatment, while a negative net-benefit suggests the reverse.
Initially, the median point estimates derived from the second
round Delphi results were used in the model. To demonstrate the
impact of the range of estimates, one way sensitivity analyses were
carried out for each of the parameters while holding all other
parameters constant at the median estimate. A tornado graph was
produced to illustrate the impact of this variation on the net-
benefit of the RDTs as determined by the model.
Ethical approval was not considered necessary for this survey as
all panellists were fully informed and consenting by taking part in
the Delphi process with no direct impact on patient care.
Results
The survey was conducted in 2008–2009. Of the 27 individuals
invited to participate in the survey, 22 panellists (81%) completed
the initial questionnaire, and 21 completed the revised question-
naire. Of the 21 panellists, 17 cited Africa as the primary area in
which they were most experienced, with the remaining citing
South and Southeast Asia. Results from the first round were used
to develop the revised questionnaire. After the second round, it
became apparent that the estimates that initially diverged widely
for most parameters had not converged, and that further
convergence of opinion with further rounds of surveying was
unlikely to occur. Further sampling would be more likely to lead to
lower response rates than better estimates. Thus, the results of
round two are presented as final.
Summary results for children under five and adults
The Delphi survey results for children under five years of age
are summarized in Tables 1a and 1b and for adults in Tables 2a
and 2b. Children in low transmission areas were considered to be
at higher risk of progressing to severe malaria (median 30% IQR
10–58%) than those living in areas of higher transmission (median
13% IQR 7–30%), but there was wide variability in the actual
prediction. The probability that severe malaria would progress to
death was judged similar in both settings (medians 73% and 60%
respectively). The likelihood that non-malarial illnesses would
require antibiotic treatment, and the outcome of untreated
bacterial illnesses, were believed to vary with HIV prevalence.
Children living in areas of high HIV prevalence were considered
by most participants to be at higher risk of bacterial illness that
would benefit from antibiotic treatment, and at greater risk of
progressing to severe illness and death if such illnesses went
untreated, than children from areas with lower HIV prevalence.
The survey results indicated a wide dispersion of expert opinion on
almost all parameters best seen in Figures 1–5, with little
convergence between rounds of questioning.
Outcome of untreated malaria
Figure 1 shows the estimates obtained for the probability that
untreated malaria would progress to severe malaria (including any
manifestation defined by WHO), stratified by age and transmission
intensity. For older patients, particularly those over 15 years of
age, living in medium/high transmission areas, some consensus
was achieved on the risk of progressing to severe malaria, with all
estimates 20% or less, and with a median of 3%. For younger
children and residents of lower transmission settings, opinions
were more diverse. For children under five years of age from
medium/high transmission areas, all but 4 panellists estimated that
the probability of progressing to severe malaria was 30% or less;
however, one panellist estimated the risk to be 80%. In lower
transmission areas, estimates of the risk that untreated cases would
progress to severe malaria ranged widely, from 5–100% for all age
groups. Estimates of the risk of developing specific manifestations
of severe malaria (cerebral malaria, severe anaemia, respiratory
distress) were more concentrated than the estimates for any WHO-
defined manifestation (see Annex S2 for detailed results). Opinions
on the probability of dying from untreated severe malaria, a key
parameter for many models were much more diverse, regardless of
age or transmission intensity, ranging from 5–100% from children
under 15 years of age, and 5–95% for older patients (Figure 2).
Outcome of untreated non-malarial illnesses
Three questions related to the outcomes for individuals with
non-malarial illness. The first of these sought to quantify the
proportion of those illnesses that are viral and considered to be
self-limiting, and those that are bacterial and require antibiotic
treatment. In areas of low HIV prevalence, the proportion of non-
malarial illnesses that could benefit from an antibiotic was judged
to be approximately 20% for all ages, with most respondents
estimating 30% or less (Figure 3). In areas of higher HIV
prevalence, the estimates were higher and more widely dispersed,
with a median of 30%. No consensus was reached on the
probability that a bacterial illness would become severe if not
treated with an antibiotic regardless of age or HIV prevalence
(Figure 4). Estimates of the probability that a severe bacterial
illness would result in death if left untreated also varied widely,
particularly in areas of high HIV prevalence (Figure 5).
Table 1. Delphi survey estimates for children under 5 years of age.
Parameter
Low/Epidemic Prone areas;
Median (IQR)
Medium/High trans-
mission; Median (IQR)
Q1 Probability untreated malaria becomes severe 30% (10–58%) 13% (7–30%)
Q2 Probability severe malaria progresses to death 73% (50–85%) 60% (45–80%)
Parameter Low HIV prevalence High HIV prevalence
Q3 Probability non-malarial illness requires antibiotics 20% (10–25%) 30% (23–40%)
Q4 Probability illness that requires antibiotics becomes severe 20% (18–50%) 40% (30–73%)
Q5 Probability that severe illness requiring antibiotics progresses to death 40% (28–50%) 50% (40–68%)
Table 1 a (above) shows the median and interquartile range for the responses provided for questions 1 and 2, relating to health outcomes of untreated malaria in
children. Table 1b (below) shows the median and interquartile range in responses to questions relating to non-malaria febrile illness in children. IQR – interquartile
range.
doi:10.1371/journal.pone.0017439.t001
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Impact of the range of probability estimates on the RDT
model outcome
To test the impact of the variation of expert opinion found in
this survey on a typical decision model the parameter values for
children under five determined by the Delphi survey (Tables 1a
and 1b) were entered into the RDT model to explore the impact of
the estimates and the dispersion of opinion. Using the median
parameter values, the model output suggests that use of an RDT to
target treatment appeared to be cost-effective in low transmission
settings (positive net benefit of $35), but not in higher transmission
settings (negative net benefit of -$30). When the full range of
estimates provided in answer to each of the Delphi survey
questions was entered into the model however, substantially
different results were produced (Figure 6). In areas with high
transmission, varying the estimate for the probability that
untreated malaria would become severe from the median (15%)
to the lowest value (1%) strengthened the negative outcome
(negative net-benefit of -$242), while entering the highest value
(80%) reversed the results and produced a positive outcome
(positive net-benefit of $12). Similar results were seen for the
probability that untreated severe malaria would lead to death in
high transmission areas. In low transmission settings, varying the
parameters for outcome of untreated malaria had less of an
impact. In both low and high HIV prevalence settings, variation in
the parameters for non-malarial illnesses had a significant impact
on the model output, leading to a reversal of the net-benefit from
positive to negative when assuming that fewer illnesses would
benefit from antibiotic treatment, or that the probability that
Table 2. Delphi survey estimates for adults.
Parameter
Low/Epidemic Prone
areas; Median (IQR)
Medium/High trans-
mission; Median (IQR)
Q1 Probability untreated malaria becomes severe 18% (5–25%) 3% (1–5%)
Q2 Probability severe malaria progresses to death 70% (50–80%) 45% (30–71%)
Low HIV prevalence High HIV prevalence
Q3 Probability non-malarial illness requires antibiotics 20% (13–28%) 30% (30–40%)
Q4 Probability illness that requires antibiotics becomes severe 20% (10–30%) 30% (23–65%)
Q5 Probability that severe illness requiring antibiotics progresses to death 30% (20–40%) 50% (35–50%)
Table 2 a (above) shows the median and interquartile range for the responses provided for questions 1 and 2, relating to health outcomes of untreated malaria in adults.
Table 2b (below) shows the median and interquartile range in responses to questions relating to non-malaria febrile illness in adults. IQR – inter-quartile range IQR –
interquartile range.
doi:10.1371/journal.pone.0017439.t002
Figure 1. Probability of developing severe illness for untreated malaria cases. The top panel shows results for low transmission or
epidemic prone areas; the bottom panel are the results for medium/high transmission areas. The median in both settings decreases with age and the
estimates also become less dispersed.
doi:10.1371/journal.pone.0017439.g001
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Figure 2. Probability of dying of untreated severe malaria. The top panel shows results for low transmission or epidemic prone areas; the
bottom panel are the results for medium/high transmission areas.
doi:10.1371/journal.pone.0017439.g002
Figure 3. Probability that non-malarial febrile illness warrants antibiotics. Non-malarial illnesses included only those where no other
obvious cause of illness is present (e.g. ear, soft tissue or urine infection).
doi:10.1371/journal.pone.0017439.g003
Delphi Survey on Untreated Acute Fevers
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Figure 5. Probability that for patients with a severe illness that could have benefited from an antibiotic, this will lead to death if
untreated.
doi:10.1371/journal.pone.0017439.g005
Figure 4. Probability that patients suffering from an illness warranting antibiotics would become severe and require
hospitalization if not untreated.
doi:10.1371/journal.pone.0017439.g004
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untreated bacterial illnesses would progress to severe illness and
death was very low (not shown). Adding the effects of all these
parameters would have led to even wider variation from net
positive to net negative.
Discussion
Models are increasingly used for economic and policy decisions,
but where data do not exist they are often based on expert opinion.
To establish estimates for key parameters in decision models of
malaria case management, a Delphi survey was conducted with
malaria experts on the consequences of untreated malaria and non-
malarial febrile illnesses. Some consensus was reached about the
probability that patients over five years of age from medium/high
transmission settings with untreated malaria would progress to severe
disease, and the probability that a non-malaria illness could benefit
from antibiotics in patients from areas of low HIV prevalence. The
ranges described here are reasonable to use for decision models.
However, the survey results indicated a wide dispersion of opinion on
most key parameters which drive model outputs, with responses to
several questions ranging from 5% to 100%. Introducing the range of
estimates into a typical model evaluating malaria RDTs demonstrat-
ed the impact that diversity of opinion and variation in parameter
values could have on such model outputs and on the policy
conclusions drawn, varying from very positive to negative. This
survey has highlighted the lack of agreement of acknowledged experts
on the central parameters required to model the management of
febrile illness suggestive of malaria, and the risks of relying on a single
expert opinion to establish model parameters in the absence of
evidence. These findings are equally important in the context of
epidemiological models that often rely on similar parameters to the
ones explored in this survey.
An understanding of the consequences of not treating, or
inadequately treating, malaria and bacterial infections is essential
for evaluating the benefits and risks of managing febrile illnesses.
In 1954, Bruce-Chwatt commented that …’morbidity due to
malaria is so imperfectly known that even an approximate estimate
of it would be merely a guess’ [22]. The results of this survey
suggest that little has changed in 50 years. Although more is
known about the epidemiology, pathophysiology, and treatment of
malaria, we still know little about the serious consequences of the
illness. In malaria-endemic areas, probably only a small propor-
tion of children with uncomplicated illness (1–2%) progress to
severe disease [6]. However, the case fatality rate of children
hospitalized with severe malaria ranges from 10–50%, and it has
been suggested that the mortality of untreated severe falciparum
malaria may reach 100% [23]. Even less is known about the
consequences of non-malarial illnesses common in Africa and
Asia. In malaria-endemic areas, at least as many children die of
non-malarial causes as die of malaria [24,25]. Many non-malarial
febrile illnesses in African children are likely to be bacterial, and
would benefit from appropriate antibiotic treatment [26,27].
To date, Delphi surveys have been used infrequently in the
context of malaria treatment and diagnostics. When chloroquine
resistance was emerging, Sudre and colleagues used a Delphi
survey to estimate mortality rates due to treatment failure amongst
children of different age groups [28]. This survey reported a 5%
mortality rate in children with highly chloroquine-resistant
infections, although the distribution of expert opinions was not
reported. By comparison, the case fatality rates in our study
(calculated by multiplying the probability of developing severe
illness by the mortality rate for severe illness) for untreated malaria
was 15% in low/epidemic prone transmission areas and 9% in
medium/high areas. In 2004, a Delphi survey was again used to
assess the contribution of ACT usage to the reduction in malaria
transmission in KwaZulu Natal [14].
The primary aim of this study was to gather estimates to be
applied in decision modelling. The simplest application of these
results would be to enter the median values into decision models.
However, given the wide dispersion of values for most estimates, at
a minimum sensitivity analyses should be conducted to explore the
impact of more extreme estimates on the model output. As
demonstrated by the experience with the RDT model reported
here, varying the estimates from the mean value to the extremes
can have a significant impact on model output, reversing possible
policy conclusions. The uncertainty demonstrated by the diver-
gence in expert opinion can be described by fitting appropriate
probability distributions for probabilistic sensitivity analyses.
Some of the variability in responses is likely to be due to
genuine heterogeneity of malaria across settings, therefore the
stratification of malaria transmission in the models is likely to
impact the assessments obtained from experts and the accuracy
of the results. Models could, for instance, broaden the
stratification beyond two or three transmission levels to allow
Figure 6. Variation in net benefit of the RDT. The net-benefit varies in response to the range of parameter estimates in the low (left) and high
(right) transmission intensity areas. The vertical axes indicate the net benefit using the median values from the survey. The grey bars relate to
estimates that are lower than the median, while the black ones indicate the range of expert estimates higher than the median. The lighter areas of
the background indicate a positive net-benefit while the darker areas are where the use of RDT would not be cost-effective. Q 1–5: Questions 1–5.
doi:10.1371/journal.pone.0017439.g006
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for greater geographical specificity. The need for more
geographically focused estimates is perhaps even greater with
non-malarial illnesses, where not only HIV prevalence is
variable, but also that of other zoonoses such as rickettsial
illnesses and leptospirosis, and endemic and epidemic pathogens
such as S. typhi and N. meniningitidis. This variation will, of course,
lead to variation in the progression to severe disease and death
outcomes as well. Another approach to handling the diverse
range of opinions would be to create interactive models, which
would allow stakeholders to enter their own estimates for some of
the more contentious parameters and produce results relevant to
local aetiology and their own circumstances [19]. Regardless of
the approach, the output of any model that utilizes parameters
with such a wide range of estimates should be interpreted with
caution.
As with all Delphi studies, this one had potential limitations.
The Delphi survey approach, including the development of the
questions, selection of panellists, processing of feedback, and
determination of the number of rounds of questioning, tends to
be subjective, although less subjective than the usual way experts
are chosen for modelling studies (the reason this study was
undertaken). For this survey, 27 panellists were invited. Our
panellists were selected for their expertise in malaria in
particular, but also their wider clinical and research experience
with non-malarial illnesses, including in bacterial diseases.
Although only 21 completed the second round of questioning,
it is unlikely that including the additional 6 would have changed
our results. No panel will be exactly representative of world
opinion, but whilst it is likely that a different sample of experts
would produce different results, it is unlikely that the opinions of
a different group would converge, particularly if a large, diverse
panel was selected. For the malaria-related estimates, the
diversity of opinions seems to reflect genuine uncertainty and
strikingly diverse views on what could ultimately be better
defined estimates of health outcomes of untreated malaria
(notwithstanding some variation due to factors not accounted
for in the questionnaire, such as co-morbidities). For the non-
malarial illnesses, it is likely that the diversity of opinions partly
reflects actual epidemiological heterogeneity.
There is no standard number of experts required for Delphi
surveys, although the number recruited for this study is at the high
end of most clinical Delphi surveys. The selection of panellists may
determine the range and nature of views expressed in the surveys
[29]. Bias may be introduced by the initial selection of the
panellists, or by non-completion. Some participants expressed
discomfort with providing answers without supporting evidence,
and in some instances did not provide an estimate for a particular
parameter- although models are constructed with estimates from
experts who are prepared to venture an opinion. The variability in
opinions could partly result from patient level heterogeneity in
factors that were not included in the survey, such as nutritional
status and concomitant illness. Decision models however will
seldom be able to capture such detail in their own structure. The
stratification by age, malaria transmission intensity and HIV
included in this survey were as detailed or more so than currently
found in decision and mathematical models.
The questionnaire revision process, unique to Delphi surveys,
may be subject to bias. In this survey, decisions to revise questions
were driven by the frequency of comments, relevance to policy
decisions, and practical considerations. This Delphi survey was
halted after two rounds due to lack of convergence on most
questions, with no indication that this would occur in further
rounds. In the past, four rounds were considered ideal for Delphi
surveys, although in more recent studies two or three rounds are
accepted as sufficient. The decision on the number of rounds
employed tends to be pragmatic, but may impact on the final
results [16,30]. There is usually a trade-off between a higher
number of rounds (which potentially increases convergence,
improving the data) and falloff in response rate (which reduces
its usefulness). Delphi surveys aim to reach consensus; however our
results suggested that convergence was unlikely to be achieved for
most parameters included in this survey. The limitations of this
study should not be overstated however; the results reflect the
variety of opinion there is in reality, and demonstrate the
shortcomings of models which tend to be based on one or at
most a small number of experts, who generally are drawn from a
far narrower pool for any given model than in this survey, and are
only sampled once. In this survey, the wide variation of opinions
likely resulted at least in part from the variability of malaria
epidemiology at the sites where the expert panel members work,
and is a testimony to the complexity of this infection.
Conclusions
Decision and economic models are widely used in policy
decisions, but depend on the key parameters used being right, or at
least in roughly the right place. This study provides an expert
panel view of key data points, but demonstrates a striking
dispersion in expert opinion on the parameters which have a
significant impact on most existing malaria treatment decision
models and models of diagnosis of febrile disease in malaria-
endemic countries. Wherever possible real data rather than expert
opinion should be used in models. Where this is not possible, the
lack of clear consensus on most of the parameters and the wide
range of estimates suggests that expert opinion should be used
cautiously in decision models, and should always be supported by
appropriate sensitivity analyses including the range of opinions
shown in this study.
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